Andere Sprachen TTY Biopharm Company Limited

Aktien

4105

TW0004105002

4105

Schlusskurs Taipei Exchange Andere Börsenplätze 00:00:00 10.05.2024			% 5 Tage	% 1. Jan.
78,4 ^TWD	+0,51 %		+1,03 %	-2,49 %

10.05.	TTY Biopharm Company Limited meldet die Ergebnisse für das erste Quartal zum 31. März 2024	CI
14.03.	TTY Biopharm Company Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

TTY Biopharm Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	10.05.
TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
TTY Biopharm Company Limited Announces Change of CFO and Financial Officer	08.03.
TTY Biopharm Company Limited Proposes Cash Dividend for the Year Ended December 31, 2023, Payable on April 26, 2024	08.03.
TTY Biopharm Company Limited Appoints Peng,Cheng-Yi as Research and Development Officer, Effective February 01, 2024	30.01.
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03.11.
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
TTY Biopharm Company Limited Receives Milestone Payment from German Pharmaceutical Company for Co-Development of Liposome Product-Pegylipo in Europe	09.08.23
TTY Biopharm Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	05.05.23
TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	14.03.23
TTY Biopharm Company Limited Proposes Dividend Distribution for the Year Ended December 31, 2022, Payable on May 5, 2023	14.03.23
DelveInsight Estimates a Diverse Kaposi Sarcoma Pipeline Comprising 5+ Companies Working in the Domain	03.03.23
Aurobindo Pharma Arm Gets US FDA Nod for Amphotericin B Liposome	18.11.22
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04.11.22
TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022	04.11.22
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022	11.08.22
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	06.08.22
TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022	05.08.22
TTY Biopharm : To clarify report of China Times, Commercial Times and Economic Daily News on Aug 02, 2022	02.08.22
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022	11.07.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen TTY Biopharm Company Limited

Aktien

4105

TW0004105002

4105

Andere Sprachen

Filter